BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1852154)

  • 1. Hepatitis C virus infection in haemodialysis patients.
    Roger SD; Crewe E; Cunningham A; Harris DC
    Aust N Z J Med; 1991 Feb; 21(1):22-4. PubMed ID: 1852154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
    Watanabe Y; Harada S; Saito I; Miyamura T
    Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
    Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
    Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma.
    Sakamoto N; Enomoto N; Marumo F; Sato C
    J Med Virol; 1993 Jan; 39(1):11-5. PubMed ID: 7678636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV transmission after receiving anti-c100-negative blood units.
    Inaba S; Fukuda M; Okochi K; Irita Y; Tokunaga K; Kiyokawa H; Maeda Y
    Lancet; 1991 Jun; 337(8753):1354. PubMed ID: 1709435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
    Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
    Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
    Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S
    Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and virological analysis of the non-A, non-B hepatitis negative for HCV antibody (anti-C-100)].
    Kamimura T; Miyajima T; Okoshi S; Kojima H; Asakura H; Shimotono K
    Nihon Rinsho; 1991 Feb; 49(2):409-11. PubMed ID: 1849201
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients.
    Yoshida CF; Takahashi Y; Vanderborght BO; Rouzere CD; França MS; Takahashi C; Takamizawa A; Yoshida I; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1993; 35(4):315-21. PubMed ID: 7509506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antibodies to hepatitis C virus in HBsAg negative hemodialysis patients.
    Salunkhe PN; Naik SR; Semwal SN; Naik S; Kher V
    Indian J Gastroenterol; 1992 Oct; 11(4):164-5. PubMed ID: 1328045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.
    Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK
    S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus replication and antibodies to structural and nonstructural viral proteins in chronic hepatitis C.
    Yuki N; Hayashi N; Hagiwara H; Naito M; Kasahara A; Fusamoto H; Kamada T
    J Hepatol; 1994 Mar; 20(3):421-5. PubMed ID: 7516952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
    Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
    Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
    Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
    Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
    J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.